National Society of Genetic Counselors annual conference
Poster # CAN62
Wednesday, October 18, 2023 5:30 - 7:00pm Abstract Poster
Emily K. Dalton, Robert Pilarski, Lauren Sferrazza, Jessica Grzybowski, Ann Marie Miller, Shelly Cummings, Kelli Conlan, Kristen Postula, Rebecca Johnson, Lisa Schlager, Robin Dubin, Fred Struve. Always better when we’re together: A novel, collaborative multi-stakeholder coalition enhances national guidelines for hereditary cancer testing and detection.
Poster # ASD31
Wednesday, October 18, 2023 5:00 - 6:30pm Abstract Poster
Chelsea Menke, Courtney Rice, Heather Fecteau, Haley Keller, Shannon Kiernan. If we build it patients will come: A healthcare system's approach to improve identification of at-risk individuals, increase genetic counseling referrals, and build patient management using a digital tool and EMR.
Poster # GGT225
Thursday, October 19, 2023 5:30 - 7:00pm Abstract Poster
Meghan Towne, Jessica Grzybowski, Jessica Gage, Jesus Ramirez Castano, Heather Zimmermann. Splicing up the diagnosis: Using targeted RNA studies to reclassify exome sequencing variants.
Poster # ASD15
Thursday, October 19, 2023 4:30 - 6:30pm Abstract Poster
Haley Keller, Deepika Nathan, Sarah Siddiqui, Heather Fecteau, Carrie Horton, Carrie Milliard, Robert Pilarski, Devon Thrush, Lukas Lyon, Shannon Kieran. Validation of patient-facing digital tool risk stratification of those at risk for hereditary cancer syndrome: The CARE program accurately identifies high risk individuals.
Session # Platform
Thursday, October 19, 2023 4:45 - 5:45pm Abstract
Andrew Giles. Addressing equity in exome sequencing: Proactive reanalysis helps to reduce racial, ethnic, and ancestral disparities
Session # Platform
Thursday, October 19, 2023 4:45 - 5:45pm Abstract
Jenny Geurts, Med College of WI. Identification of high-risk hereditary cancer syndrome patients in a primary care cohort using a patient-facing risk stratification tool
Session # Educational Breakout Session
Thursday, October 19, 2023 11:00 - 12:30pm
Marcy Richardson, PhD; Tuya Pal (Vanderbilt), Erin Mundt (Myriad), Matthew Lebo (LMMM), Yeni Rodriguez Sanabria. Not all actionable variants in BRCA1 and BRCA2 are created equal: Challenges of classifying and interpreting reduced-penetrance variants
Session # Breakfast Symposia
Friday, October 20, 2023 7:45 - 8:30am
Meagan Farmer, MS, MBA, LCGC; Meghan Towne, MS, CGC; LGC Kelly Minks, MS, CGC. Reassessed and revealed: Patient and genetic counselor experience with proactive reanalysis